Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
P/S ratio for Arbutus Biopharma (ABUS)
P/S ratio as of May 2024 (TTM): 26.6
According to Arbutus Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 26.6176. At the end of 2023 the company had a P/S ratio of 23.1.
P/S ratio history for Arbutus Biopharma from 2008 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 23.1 | 147.34% |
| 2022 | 9.34 | -81.94% |
| 2021 | 51.7 | 18.69% |
| 2020 | 43.6 | 45.52% |
| 2019 | 30.0 | -18.67% |
| 2018 | 36.8 | 41.76% |
| 2017 | 26.0 | -71.16% |
| 2016 | 90.1 | 823.01% |
| 2015 | 9.76 | -57.05% |
| 2014 | 22.7 | 131.77% |
| 2013 | 9.81 | 93.72% |
| 2012 | 5.06 | 369.34% |
| 2011 | 1.08 | -52.64% |
| 2010 | 2.28 | -37.33% |
| 2009 | 3.63 | 141.78% |
| 2008 | 1.50 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |
 NRC Health
NRC | 5.62 | -78.89% | 🇺🇸 USA |